Mintz advised the placement agents in connection with the $39 Million private placement that is expected to close in connection with the completion of the merger transaction between Scancell Holdings plc and Neuphoria Therapeutics Inc. The private placement is part of up to $89 Million of financing expected to be raised by Scancell in connection with the merger transaction through a combination of equity and debt.

Leerink Partners, TD Cowen and H.C. Wainwright & Co. are acting as placement agents for the private placement.

The Mintz capital markets team included William Hicks, John Rudy, Nishant Dharia, and Zach Irwin. Members of the Mintz team are based in Boston and New York.